Evidence map›Paper›PMID 38390548›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Cavernous Hepatic Hemangioma at 18F-Choline Positron Emission Tomography-Computed Tomography: Be Aware of the Pitfall.

Anna Margherita Maffione, Luca Urso, Modonesi Caterina, Sotirios Chondrogiannis, Gaia Grassetto, Paola Bartoletti, Maria Cristina Marzola

Open access · hybridAbstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Anna Margherita MaffioneDepartment of Nuclear Medicine Unit, AULSS5 Polesana, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
Luca UrsoDepartment of Nuclear Medicine Unit, AULSS5 Polesana, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
Modonesi CaterinaOncology Unit, AULSS6 Euganea, Ospedali Riuniti Padova Sud, Monselice, PD, Italy.
Sotirios ChondrogiannisDepartment of Nuclear Medicine Unit, AULSS5 Polesana, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
Gaia GrassettoDepartment of Nuclear Medicine Unit, AULSS5 Polesana, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
Paola BartolettiDepartment of Nuclear Medicine Unit, AULSS5 Polesana, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
Maria Cristina MarzolaDepartment of Nuclear Medicine Unit, AULSS5 Polesana, Santa Maria Della Misericordia Hospital, Rovigo, Italy.
Azienda Ospedaliero Universitaria Ospedali Riuniti · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a patient performing a positron emission tomography-computed tomography (PET-CT) scan with [18F]F-Choline for biochemical relapse (Prostate specific antigen (PSA) 1.2 ng/ml) of prostate cancer. Two large areas of focal uptake with a cold core within the liver were observed. A contrast-enhanced ultrasound scan performed after the PET scan characterized these lesions as cavernous hepatic hemangiomas, and therefore, a biopsy was not performed; 3 years of follow-up and PET and MRI finding stability confirmed the benignity of their nature.

Indexed as

18F-choline positron emission tomography–computed tomographycavernous hepatic hemangiomascontrast-enhanced ultrasoundhepatocellular carcinomapositron emission tomography–computed tomographyprostate cancer

Identifiers

PMID38390548
PMCPMC10880850
OpenAlexW4390072550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.